Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jin Bo Yue"'
Autor:
Jin Cui, Jin Bo Yue
Publikováno v:
Precision Radiation Oncology. 3:29-34
Autor:
Jia Yang1,2, Jin-Bo Yue2 jinbo.yue@gmail.com, Jing Liu3, Xin-Dong Sun2, Xu-Dong Hu1, Ju-Jie Sun4, Yu-Hui Li4, Jin-Ming Yu2
Publikováno v:
Contemporary Oncology / Współczesna Onkologia. 2014, Vol. 18 Issue 4, p260-267. 8p.
Publikováno v:
Oncology Letters. 2014, Vol. 7 Issue 6, p1755-1760. 6p.
Autor:
Jia Yang, Guang Hui Bai, Jin Bo Yue, Yu-Hui Li, Jason D. Lee, Jing Liu, Alvin R. Cabrera, Jin Ming Yu, Xin Dong Sun
Publikováno v:
Radiotherapy and Oncology. 111:475-481
Background and purpose FaDu human squamous cell carcinoma (FaDu-hSCC) demonstrates accelerated tumor repopulation during fractionated irradiation with pathological validation (Ki-67 and BrdUrd makers) in a xenograft model system. However, these and o
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 136:883-889
The purpose of this study was to evaluate the prognostic value of metabolic tumor volume (MTV) and metabolic index (MI) from fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) in patients with nasophary
Autor:
Jin-Bo, Yue, Jia, Yang, Jing, Liu, Jason, Lee, Alvin R, Cabrera, Xin-Dong, Sun, Guang-Hui, Bai, Yu-Hui, Li, Jin-Ming, Yu
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 111(3)
FaDu human squamous cell carcinoma (FaDu-hSCC) demonstrates accelerated tumor repopulation during fractionated irradiation with pathological validation (Ki-67 and BrdUrd makers) in a xenograft model system. However, these and other functional assays
Publikováno v:
Zhonghua zhong liu za zhi [Chinese journal of oncology]. 32(8)
To evaluate the value of (18)F-FDG PET-CT for assessment of therapeutic response and prediction of patient outcome after concurrent chemoradiotherapy (CCRT) of non-small cell lung cancer (NSCLC).Forty six patients with histologically proven stage III
Publikováno v:
Zhonghua zhong liu za zhi [Chinese journal of oncology]. 31(6)
Publikováno v:
European journal of radiology. 77(1)
Objective To evaluate 18 FDG PET-CT for the assessment of therapy response and prediction of patient outcome after concurrent chemoradiotherapy (CCRT) for non-small cell lung cancer (NSCLC). Methods Forty-six patients with pathologically proven stage
Publikováno v:
Zhonghua zhong liu za zhi [Chinese journal of oncology]. 30(6)